BCCFH Infusion Center

The BCCFH COVID Task Force operates an outpatient COVID-19 treatment program that is free to patients.

Multiple types of treatments are available through its three main service lines, which are: 

COVID Treatment Services

BCCFH Infusion Center

Located at the intersection of Greene and Lombard Streets in Baltimore (see location information), BCCFH COVID Task Force Infusion Center provides remdesivir therapy to patients age 12 and older who test positive for COVID-19 and are at high risk for severe disease. 

The Infusion Center sees patients by appointment only. To make an appointment, you must be referred by a provider or go through our self-referral telehealth program.  We do not see walk-in patients, and the staff here are not available answer general COVID questions or schedule for any of our services. 

Our Care Coordination Team will review the referral form and contact the patient to coordinate services as soon as possible. Providers should alert their patients to expect a call from us. We will do everything we can to send providers timely e-mail notification whether we will be able to schedule referred patients. To expedite this, please provide an email address in your referral.

Provider Referrals

Use the yellow button below to refer patients directly for infusion treatment.

Important Note for Medical Providers: As of November 25, 2022, the BCCFH COVID Task Force no longer uses monoclonal antibody therapy (bebtelovimab) to treat COVID infections. This is in accordance with NIH guidelines given that the majority of current COVID infections in our region are due to resistant variants. Find current information about variant incidence (select HHS Region 3).  We continue to offer treatment with remdesivir.

Patient Self-Referral Telehealth Program

This program offers COVID-19 treatments to patients age 18 and older who do not have medical providers or are not able to get a timely appointment with their doctors.

Patients: Contact our Care Coordination Team by calling 410-649-6122 Monday through Friday 8 am to 5 pm or by clicking on the yellow button below to complete the online self-referral form.

We review all self-referrals, and patients who may qualify for COVID-19 treatment will be scheduled for a telehealth visit. At that visit, our provider will work you to determine which type of treatment would be best for you. Providers can prescribe oral medications or refer patients for infusion therapy throughout the state, including at our BCCFH Infusion Center.

Please make sure to enter an accurate telephone number and email address so the Care Coordination Team can reach you.

Self-Referral for COVID Treatment

Test to Treat Program at State Center

This program offers patients who are feeling sick and find out they have COVID during their testing visit the opportunity to be evaluated for treatment. The Test to Treat program operates during all testing sessions at State Center.

Medical providers determine whether you meet criteria for treatment and if so, make treatment recommendations for you. The types of treatments we  offer through this program include giving you oral medications to take at home or scheduling you for infusion treatment, given through an IV, at our Infusion Center. 

You will need to bring a complete list of medications you take to your testing appointment. If you qualify for treatment, your visit might last an hour or more if the line is very long. 
Although our services are free, if you have insurance, we may bill your insurance for the visit, so bring your insurance card. You do not need to have insurance to be tested and treated. 

Important Note for Patients: If you have tested positive already — either at home or at another testing site — do not come to State Center for treatment. Instead, complete an online, self-referral form to be considered for a telehealth visit, which is free to patients. Learn more about COVID telehealth visits.

Schedule a COVID Test

Cost of Treatment

Treatments provided by the BCCFH COVID-19 Treatment Program are FREE for patients.

Health insurance is not required to receive treatment from us. If a patient has health insurance, the insurance may be charged for this care, but the patient should not be billed for copays or deductibles.

If a BCCFH provider refers you to another location for infusion treatment, please ask that organization about their billing practices when you schedule with them.  

Available COVID Treatments

All medications offered by the BCCFH COVID Treatment Program have been shown to reduce the risk of severe COVID-19 illness, including hospitalization and death, in patients who have conditions that make them more likely to have severe COVID infections. 

To qualify for these treatments, patients must have a positive test result and have symptoms from their COVID-19 infection as well as have conditions that place them at high risk of severe COVID-19 illness.

Paxlovid (Oral Medication)

Nirmatrelvir/ritonavir (brand name Paxlovid) is considered first-line outpatient treatment for COVID-19 infections. It is a pill taken twice daily for five days, and it must be started within five days of symptom onset. 

This medication was given Emergency Use Authorization (EUA) by the FDA for outpatient treatment of COVID-19 in high-risk patients aged 12 and older. 

You can learn more about the medication by reading the FDA Paxlovid Provider Fact Sheet or the FDA Paxlovid Patient Fact Sheet.

BCCFH providers prescribe Paxlovid to telehealth patients who qualify for this treatment, and our Test to Treat program dispenses this medication at our Preston Street testing location when providers determine it is appropriate.

Remdesivir (IV Therapy)

Remdesivir (brand name Veklury), which is administer by IV (through a vein), must be started within seven days from symptom onset. Remdesivir is generally reserved for patients who are unable to take Paxlovid due to specific contraindications or drug-drug interactions.

It is fully authorized by the FDA for patients 12 and older and authorized under Emergency Use Authorization (EUA) for some patients younger than 12 years old. BCCFH Infusion Center offers remdesivir therapy to patients age 12 and older.

The medication must be given three days in a row, so patients will have to come to our Infusion Center three consecutive days. On the first day of therapy, patients will have labs drawn to check liver function before their first infusion. 

You can learn more about the medication by reading the FDA Remdesivir Prescribers Information Sheet or the Remdesivir Patient Website

Monoclonal Antibody (mAb) Treatment (IV Therapy)

This treatment option is no longer recommended in Maryland now that the majority of infections are caused by COVID variants resistant to monoclonal antibody therapy. It is not available from BCCFH COVID Task force

Molnupiravir (Oral Medication)

Molnupiravir is a pill that must be started within five days of when symptoms begin. The medication is taken twice daily for five days.

This medication was given Emergency Use Authorization (EUA) by the FDA for outpatient treatment of COVID-19 in high-risk patients aged 18 and older who have tested positive for COVID-19, have mild-to-moderate symptoms not requiring hospitalization and are considered to be at high risk of hospitalization or death from COVID-19.

Our medical providers work with patients during telehealth and Test to Treat visits at State Center to determine if this is an appropriate treatment option. You can learn more about the medication by reading the FDA Molnupiravir Provider Fact Sheet or the FDA Molnupiravir Patient Fact Sheet.

Getting to the BCCFH Infusion Center

BCCFH Modular Care Unit

Location: The BCCFH Infusion Center is located at the corner of Greene and Lombard Streets in a temporary building on University of Maryland Medical Center (UMMC) Downtown Campus.  

Appointment only: Patients must have an appointment to come to the Infusion Center. Walk-ins are not accepted. Please see the information above to learn how to be seen here.

Patients arriving and departing by car may be dropped off and picked up in the lot next to the Infusion Center. To enter that lot from Greene Street, turn left just after you pass Lombard Street.

Aerial view of BCCFH Infusion Center

When you arrive, security personnel will greet you and let you know how to proceed.


Subject to availability, The BCCFH COVID-19 Treatment Program may be able to arrange for free transportation to and from appointments for patients who do not have access to safe transportation options. The Care Coordination Team will check on availability during the scheduling process.


Safe, convenient patient parking is available at several locations near the BCCFH Infusion Center, including: 

  • Medical Center Garage, Greene St, between Lombard and Pratt shares the same lot as the BCCFH Infusion Center (#3 in the parking map link below). Validation is available to reduce rate to $7.
  • The underground University Plaza Garage on West Redwood Street, just opposite University of Maryland Medical Center and the University of Maryland Professional Building, is reserved for patient parking. Validation is available to reduce rate to $9.

For more parking options, please see Parking Map at UMMC


Operated by:


Logos of University of Maryland Medical System, Johns Hopkins Medicine and Maryland Department of Health